ursolic acid has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Gong, Y; Qi, MY; Wang, XT; Yang, JJ; Zhao, JG; Zhou, B | 1 |
1 other study(ies) available for ursolic acid and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats.
Topics: Animals; Chemokine CCL2; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Down-Regulation; Fibrosis; Gene Expression Regulation; Inflammation; Male; Matrix Metalloproteinase 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Streptozocin; Transforming Growth Factor beta1; Triterpenes; Tumor Necrosis Factor-alpha; Up-Regulation; Ursolic Acid | 2018 |